| Dr Donald James Gibertini, DO | |
|
5955 Rand Blvd, Sarasota, FL 34238-5160 | |
| (941) 552-7508 | |
| (941) 552-7605 |
| Full Name | Dr Donald James Gibertini |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 5955 Rand Blvd, Sarasota, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497771125 | NPI | - | NPPES |
| IL833Z | Other | FL | MEDICARE PTAN |
| Entity Name | The Hospice Of The Florida Suncoast, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124028204 PECOS PAC ID: 5698677904 Enrollment ID: O20040126000439 |
News Archive
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date of their diagnosis.
Recent figures show that the incidence of bowel cancer in young people has surged in the past decade, more than doubling in some age categories. But doctors have been unable to explain the increase.
A startling new study shows that cells that are exquisitely sensitive to oxytocin are found in a tiny region in the brains of female but not male mice. This could be of great importance in explaining maternal behavior in females and eventually in treating social disorders like postpartum depression and autism spectrum disorder.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
With a 95 percent genomic similarity to humans, mice have long been used to learn about the genetic causes of human disease. Once researchers can shine a light on the genetic factors that cause disease in mice, they can start to develop prevention and treatment options to protect the human population.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald James Gibertini, DO 5955 Rand Blvd, Sarasota, FL 34238-5160 Ph: (941) 552-7508 | Dr Donald James Gibertini, DO 5955 Rand Blvd, Sarasota, FL 34238-5160 Ph: (941) 552-7508 |
News Archive
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date of their diagnosis.
Recent figures show that the incidence of bowel cancer in young people has surged in the past decade, more than doubling in some age categories. But doctors have been unable to explain the increase.
A startling new study shows that cells that are exquisitely sensitive to oxytocin are found in a tiny region in the brains of female but not male mice. This could be of great importance in explaining maternal behavior in females and eventually in treating social disorders like postpartum depression and autism spectrum disorder.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
With a 95 percent genomic similarity to humans, mice have long been used to learn about the genetic causes of human disease. Once researchers can shine a light on the genetic factors that cause disease in mice, they can start to develop prevention and treatment options to protect the human population.
› Verified 9 days ago
Dr. Armani Orihuela, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6128 S Tamiami Trl, Sarasota, FL 34231 Phone: 941-923-5882 Fax: 941-923-3836 | |
Sy Rabins, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 921 S Beneva Rd, Sarasota, FL 34232 Phone: 941-365-7390 Fax: 941-365-5469 | |
Kimberly Lynn Tyler, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 2415 University Pkwy Ste 218, Sarasota, FL 34243 Phone: 941-955-6220 | |
Arthur T Magrann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2414 Bee Ridge Rd, Sarasota, FL 34239 Phone: 941-951-6800 Fax: 941-929-7773 | |
Dr. David Frankel, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8383 S Tamiami Trl Unit 115, Sarasota, FL 34238 Phone: 941-244-9430 Fax: 941-244-9437 | |
Anit Dolores Ford, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3920 Bee Ridge Rd Ste H, Sarasota, FL 34233 Phone: 941-926-8855 Fax: 844-388-6186 | |
Nadia F Hanna, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3333 Clark Rd, Suite 190, Sarasota, FL 34231 Phone: 941-922-1400 Fax: 877-645-3318 |